Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Potential applications for plasmacytoid dendritic cells in cancer immunotherapy.

Tel J, de Vries IJ.

Immunotherapy. 2012 Oct;4(10):979-82. doi: 10.2217/imt.12.115. Review. No abstract available.

PMID:
23148748
2.

Plasmacytoid dendritic cells and immunotherapy in multiple sclerosis.

von Glehn F, Santos LM, Balashov KE.

Immunotherapy. 2012 Oct;4(10):1053-61. doi: 10.2217/imt.12.117. Review.

3.

The therapeutic role of dendritic cells in cancer immunotherapy.

Lemoli RM, Curti A, Fogli M, Ferri E, Baccarani M.

Haematologica. 2002 Aug;87(8 Suppl):62-6. Review. No abstract available.

PMID:
12412393
4.

Dendritic cell immunotherapy for the treatment of neoplastic disease.

Decker WK, Xing D, Shpall EJ.

Biol Blood Marrow Transplant. 2006 Feb;12(2):113-25. Review.

5.

How effective could laser-based approaches be in assisting dendritic cell immunotherapy?

Chen X, Wu MX.

Immunotherapy. 2012 Oct;4(10):983-5. doi: 10.2217/imt.12.101. No abstract available.

PMID:
23148749
6.

Significance of regional draining lymph nodes in the development of tumor immunity: implications for cancer immunotherapy.

Zheng R, Kjaergaard J, Lee WT, Cohen PA, Shu S.

Cancer Treat Res. 2007;135:223-37. Review. No abstract available.

PMID:
17953420
7.

Genetically modified dendritic cells in cancer immunotherapy: a better tomorrow?

Shurin MR, Gregory M, Morris JC, Malyguine AM.

Expert Opin Biol Ther. 2010 Nov;10(11):1539-53. doi: 10.1517/14712598.2010.526105. Review.

PMID:
20955111
8.

Personalized cancer vaccines.

Jain KK.

Expert Opin Biol Ther. 2010 Dec;10(12):1637-47. doi: 10.1517/14712598.2010.531256. Epub 2010 Oct 28. Review.

PMID:
20979567
9.

Dendritic cells in tumor immunology and immunotherapy.

Turtle CJ, Hart DN.

Curr Drug Targets. 2004 Jan;5(1):17-39. Review.

PMID:
14738216
10.

Dendritic cell activation kinetics and cancer immunotherapy.

Bellone M, Camporeale A, Boni A.

J Immunol. 2004 Mar 1;172(5):2727-8. No abstract available.

11.

Immunotherapy using dendritic cells picks up steam.

McCann J.

J Natl Cancer Inst. 1997 Apr 16;89(8):541-2. No abstract available.

PMID:
9106639
12.

Cellular immunotherapy with dendritic cells in cancer: current status.

Nencioni A, Brossart P.

Stem Cells. 2004;22(4):501-13. Review.

13.

[Cell therapy in solid tumors].

Ravaud A.

Bull Cancer. 2001 Jan;88(1):91-100. Review. French. No abstract available.

14.

Dendritic cell immunotherapy: mapping the way.

Figdor CG, de Vries IJ, Lesterhuis WJ, Melief CJ.

Nat Med. 2004 May;10(5):475-80. Review.

PMID:
15122249
15.

Dendritic cell-based cancer therapy.

Conrad C, Nestle FO.

Curr Opin Mol Ther. 2003 Aug;5(4):405-12. Review.

PMID:
14513684
16.

Tumor-dendritic cell fusion technology and immunotherapy strategies.

Shu S, Cohen P.

J Immunother. 2001 Mar-Apr;24(2):99-100. No abstract available.

PMID:
11265778
17.
18.

Dendritic cell-based vaccines and therapies for cancer.

Tatsumi T, Storkus WJ.

Expert Opin Biol Ther. 2002 Dec;2(8):919-28. Review.

PMID:
12517270
19.

Current issues in dendritic cell cancer immunotherapy.

López JA, Hart DN.

Curr Opin Mol Ther. 2002 Feb;4(1):54-63. Review.

PMID:
11885565
20.

Third international Dresden symposium on immunotherapy of cancer.

Schmitz M, Bornhauser M, Ockert D, Rieber EP.

Cancer Res. 2001 Apr 15;61(8):3524-8. No abstract available.

Supplemental Content

Support Center